More potent inhibition of human CYP2A6 than mouse CYP2A5 enzyme activities by derivatives of phenylethylamine and benzaldehyde

References

• AITIO, A., 1978, A simple and sensitive assay of 7-ethoxycoumarin deethylation. Analytical Biochemistry, 85, 488–491.
   PubMed Web of Science ®Google Scholar
• BOGAN, D. P., DEASY, B., O'KENNEDY, R., SMYTH, M. R. and FUHR, U., 1995, Determination of free and total 7-hydroxycoumarin in urine and serum by capillary electrophoresis. Journal of Chromatography B Biomedical Applications, 663, 371–378.
   Google Scholar
• CHANG, T. K. H. and WAXMAN, D. J., 1996, The CYP2A subfamily. In C. Ioannides (ed.), Cytochromes P450 Metabolic and Toxicological Aspects (Guildford: CRC Press), pp. 99–134.
   Google Scholar
• COON, M. J., VAZ, A. D., MCGINNITY, D. F. and PENG, H. M., 1998, Multiple activated oxygen species in P450 catalysis: contributions to specificity in drug metabolism. Drug Metabolism and Disposition, 26, 1190–1193.
   PubMed Web of Science ®Google Scholar
• CORNISH-BOWDEN, A., 1995, Fundamentals of Enzyme Kinetics (London: Portland).
   Google Scholar
• DRAPER, A. J., MADAN, A. and PARKINSON, A., 1997, Inhibition of coumarin 7-hydroxylase activity in human liver microsomes. Archives of Biochemistry and Biophysics, 341, 47–61.
   PubMed Web of Science ®Google Scholar
• FUJITA, K. and KAMATAKI, T., 2001, Screening of organosulfur compounds as inhibitors of human CYP2A6. Drug Metabolism and Disposition, 29, 983–989.
   PubMed Web of Science ®Google Scholar
• GREENLEE, W. F. and POLAND, A., 1978, An improved assay of 7-ethoxycoumarin 0-deethylase activity: induction of hepatic enzyme activity in C57BL/6J and DBA/2J mice by phenobarbital, 3-methylcholantherene and 2,3,7,8-tetrachloro-p-dioxin. Journal of Pharmacology and Experi-mental Therapeutics, 205, 596–605.
   PubMed Web of Science ®Google Scholar
• HILLER, D. L. and COLE, R. O., 1995, Short-column gradient elution high-performance liquid chromatography for the rapid determination of 7-ethoxycoumarin metabolites in liver-slice incubates. Analytical Biochemistry, 227, 251–254.
   PubMedGoogle Scholar
• INouE, K., YAMAZAKI, H. and SHIMADA, T., 2000, CYP2A6 genetic polymorphisms and liver microsomal coumarin and nicotine oxidation activities in Japanese and Caucasians. Archives of Toxicology, 73, 532–539.
   PubMed Web of Science ®Google Scholar
• JUVONEN, R., KAIPAINEN, P. K. and LANG, M. A., 1985, Selective induction of coumarin 7-hydroxylase by pyrazole in D2 mice. European Journal of Biochemistry, 152, 38.
   Google Scholar
• JUVONEN, R. O., GYNTHER, J., PASANEN, M., ALHAVA, E. and Poso, A., 2000, Pronounced differences in inhibition potency of lactone and non-lactone compounds for mouse and human coumarin 7-hydroxylases (CYP2A5 and CYP2A6). Xenobiotica, 30, 81–92.
   PubMed Web of Science ®Google Scholar
• KIMONEN, T., JUVONEN, R. O., ALHAVA, E. and PASANEN, M., 1995, The inhibition of CYP enzymes in mouse and human liver by pilocarpine. British Journal of Pharmacology, 114, 832–836.
   PubMed Web of Science ®Google Scholar
• KITAGAWA, K., KUNUGITA, N., KATOH, T., YANG, M. and KAWAMOTO, T., 1999, The significance of the homozygous CYP2A6 deletion on nicotine metabolism: a new genotyping method of CYP2A6 using a single PCR-RFLP. Biochemical and Biophysical Research Communications, 262, 146–151.
   PubMed Web of Science ®Google Scholar
• KITZ, R. and WILSON, I. B., 1962, Esters of methanesulfonic acid as irreversible inhibitors of acetylcholinesterase. Journal of Biological Chemistry, 237, 3245–3249.
   PubMed Web of Science ®Google Scholar
• KOENIGS, L. L., PETER, R. M., THOMPSON, S. J., RETTIE, A. E. and TRAGER, W. F., 1997, Mechanism-based inactivation of human liver cytochrome P450 2A6 by 8-methoxypsoralen. Drug Metabolism and Disposition, 25, 1407–1415.
   PubMed Web of Science ®Google Scholar
• KOSKELA, S., HAKKOLA, J., HUKKANEN, J., PELKONEN, O., SORRI, M., SARANEN, A., ANTTILA, S., FERNANDEZ-SALGUERO, P., GONZALEZ, F. and RAUNIO, H., 1999, Expression of CYP2A genes in human liver and extrahepatic tissues. Biochemical Pharmacology, 57, 1407–1413.
   Google Scholar
• LAMIABLE, D., VISTELLE, R., TRENQUE, T., FAY, R., MILLART, H. and CHOISY, H., 1993, Sensitive high-performance liquid chromatographic method for the determination of coumarin in plasma. Journal of Chromatography, 620, 273–277.
   PubMed Web of Science ®Google Scholar
• LANG, M. A. and NEBERT, D. W., 1981, Structural gene products of the Ah locus. Evidence for many unique P-450-mediated monooxygenase activities reconstituted from 3-methylcholanthrene-treated C57BL/6N mouse liver microsomes. Journal of Biological Chemistry, 256, 12058–12067.
   PubMedGoogle Scholar
• LEWIS, D. F. and LAKE, B. G., 2002, Species differences in coumarin metabolism: a molecular modelling evaluation of CYP2A interactions. Xenobiotica, 32, 547–561.
   PubMed Web of Science ®Google Scholar
• LINDBERG, R. L. P. and NEGISHI, M., 1989, Alteration of mouse cytochrome P450coh substrate specificity by mutation of a single amino-acid residue. Nature, 339, 632–634.
   Google Scholar
• LUDBROOK, J., 1997, Comparing methods of measurements. Clinical and Experimental Pharmacology and Physiology, 24, 193–203.
   PubMed Web of Science ®Google Scholar
• MAENPAA., J., SIGUSCH, H., RAUNIO, H., SYNGELMA, T., VUORELA, P., VUORELA, H. and PELKONEN, O., 1993, Differential inhibition of coumarin 7-hydroxylase activity in mouse and human liver microsomes. Biochemical Pharmacology, 45, 1035–1042.
   PubMed Web of Science ®Google Scholar
• MILES, J. S., MCLAREN, A. W., FORRESTER, L. M., GLANCEY, M. J., LANG, M. A. and WOLF, C. R., 1990, Identification of the human liver cytochrome P-450 responsible for coumarin 7-hydroxylase activity. Biochemical Journal, 267, 365–371.
   PubMed Web of Science ®Google Scholar
• MIYAMOTO, M., UMETSU, Y DOSAKA-AKITA, H., SAWAMURA, Y., YOKOTA, J., KUNITOH, H., NEMOTO, N., SATO, K., ARIYOSHI and KAMATAKI, T., 1999, CYP2A6 gene deletion reduces susceptibility to lung cancer. Biochemical and Biophysical Research Communications, 261, 658–660.
   Google Scholar
• NAKAJIMA, M., YAMAGISHI, S. I., YAMAMOTO, H., YAMAMOTO, T., KUROIWA, Y. and YOKOI, T., 2000, Deficient cotinine formation from nicotine is attributed to the whole deletion of the CYP2A6 gene in humans. Clinical Pharmacology and Therapeutics, 67, 57–69.
   PubMed Web of Science ®Google Scholar
• OSCARSON, M., 2001, Genetic polymorphisms in the cytochrome P450 2A6 (CYP2A6) gene: implications for interindividual differences in nicotine metabolism. Drug Metabolism and Disposition, 29, 91–95.
   PubMed Web of Science ®Google Scholar
• PELKONEN, O., RAUTIO, A., RAUNIO, H. and PASANEN, M., 2000, CYP2A6: a human coumarin 7-hydroxylase. Toxicology, 144, 139–147.
   PubMed Web of Science ®Google Scholar
• PELKONEN, O., RAUNIO, H., RAUTIO, A., PASANEN„ M. and LANG, M. A., 1997, The metabolism of coumarin. In R. O'Kennedy and R. D. Thornes (eds), Coumarins: Biology, Applications and Mode of Action (Chichester: Wiley), pp. 67–92.
   Google Scholar
• Poso, A., GYNTHER, J. and JUVONEN, R., 2001, A comparative molecular field analysis of cytochrome P450 2A5 and 2A6 inhibitors. Journal of Computer-Aided Molecular Design, 15, 195–202.
   PubMed Web of Science ®Google Scholar
• RANER, G. M., CHIANG, E. W., VAZ, A. D. and COON, M. J., 1997, Mechanism-based inactivation of cytochrome P450 2B4 by aldehydes: relationship to aldehyde deformylation via a peroxyhemiacetal intermediate. Biochemistry, 36, 4895–4902.
   PubMed Web of Science ®Google Scholar
• RAUNIO, H., RAUTIO, A., GULLSTEN, H. and PELKONEN, O., 2001, Polymorphisms of CYP2A6 and its practical consequences. British Journal of Clinical Pharmacology, 52, 357–363.
   PubMed Web of Science ®Google Scholar
• SELLERS, E. M., KAPLAN, H. L. and TYNDALE, R. F., 2000, Inhibition of cytochrome P450 2A6 increases nicotine's oral bioavailability and decreases smoking. Clinical Pharmacology and Therapeutics, 68, 35–43.
   PubMed Web of Science ®Google Scholar
• SMITH, P. K., KROHN, R. I., HERMANSON, G. T., MALLIA, A. K., GARTNER, F. H., PROVENZANO, M. D., FUJIMOTO, E. K., GOEKE, N. M., OLSON, B. J. and KLENK, D. C., 1985, Measurement of protein using bicinchoninic acid. Analytical Biochemistry, 150, 76–85.
   PubMed Web of Science ®Google Scholar
• TAAVITSAINEN, P., JUVONEN, R. and PELKONEN, O., 2001, In vitro inhibition of cytochrome P450 enzymes in human liver microsomes by a potent CYP2A6 inhibitor, trans-2-phenylcyclopropylamine (tranylcypromine), and its nonamine analog, cyclopropylbenzene. Drug Metabolism and Disposition, 29, 217–222.
   PubMed Web of Science ®Google Scholar
• TYNDALE, R. F. and SELLERS, E. M., 2001, Variable CYP2A6-mediated nicotine metabolism alters smoking behavior and risk. Drug Metabolism and Disposition, 29, 548–552.
   PubMed Web of Science ®Google Scholar
• TYNDALE, R. F. and SELLERS, E. M., 2002, Genetic variation in CYP2A6-mediated nicotine metabolism alters smoking behavior. Therapeutic Drug Monitoring, 24, 163–171.
   PubMed Web of Science ®Google Scholar
• VAN TEASEL, M., WALTERS, D. G., PRICE, R. J., LOVELL, D. P. and LAKE, B. G., 1994, Sex and strain differences in mouse hepatic microsomal coumarin 7-hydroxylase activity. Food and Chemical Toxicology, 32, 387–390.
   PubMedGoogle Scholar
• VAZ, A. D., PERNECKY, S. J., RANER, G. M. and COON, M. J., 1996, Peroxo-iron and oxenoid-iron species as alternative oxygenating agents in cytochrome P450-catalyzed reactions: switching by threonine-302 to alanine mutagenesis of cytochrome P450 2B4. Proceedings of the National Academy of Sciences, USA, 93, 4644–4648.
   PubMed Web of Science ®Google Scholar
• WEN, X., WANG, J. S., NEUVONEN, P. J. and BACKMAN, J. T., 2002, Isoniazid is a mechanism-based inhibitor of cytochrome P450 1A2, 2A6, 2C19 and 3A4 isoforms in human liver microsomes. European Journal of Clinical Pharmacology, 57, 799–804.
   PubMed Web of Science ®Google Scholar
• WOOD, A. W., 1979, Genetic regulation of coumarin hydroxylase activity in mice. Biochemical characterization of the enzyme from two inbred strains and their Fl hybrid. Journal of Biological Chemistry, 254, 5641–5646.
   PubMed Web of Science ®Google Scholar
• YAMANO, S., TATSUNO, J. and GONZALEZ, F. J., 1990, The CYP2A3 gene product catalyzes coumarin 7-hydroxylation in human liver microsomes. Biochemistry, 29, 1322–1329.
   PubMed Web of Science ®Google Scholar
• ZHANG, W., KILICARSLAN, T., TYNDALE, R. F. and SELLERS, E. M., 2001, Evaluation of methoxsalen, tranylcypromine, and tryptamine as specific and selective CYP2A6 inhibitors in vitro. Drug Metabolism and Disposition, 29, 897–902.
   PubMed Web of Science ®Google Scholar